Cargando…
Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
BACKGROUND AND AIM: Azathioprine (AZA) forms the cornerstone for maintenance of sustained remission in inflammatory bowel disease (IBD). There is apprehension regarding the long‐term effectiveness and safety of AZA in IBD. We present our experience with AZA use and outcomes in a cohort of IBD patien...
Autores principales: | Yewale, Rohan V, Ramakrishna, Balakrishnan S, Doraisamy, Babu Vinish, Basumani, Pandurangan, Venkataraman, Jayanthi, Jayaraman, Kayalvizhi, Murali, Ananthavadivelu, Premkumar, Karunakaran, Kumar, Akkim Sathish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517446/ https://www.ncbi.nlm.nih.gov/pubmed/37744710 http://dx.doi.org/10.1002/jgh3.12955 |
Ejemplares similares
-
Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study
por: Yewale, Rohan Vijay, et al.
Publicado: (2023) -
Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices
por: Yewale, Rohan V, et al.
Publicado: (2021) -
Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
por: Ramakrishna, Banumathi, et al.
Publicado: (2020) -
Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011) -
Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease
por: Wilson, Laura, et al.
Publicado: (2020)